Search Results
The heavily regulated and IP-driven life sciences industry operates in a state of continual flux. This dynamic nature of the industry throws a diverse mix of powerful challenges and equally promising opportunities at the pharmaceutical executive all the time.
Some of the key challenges facing pharmaceutical companies at the moment are:
- A patent cliff
- Dwindling pipelines and late-stage attritions
- Rising cost of commercialization
- A host of healthcare cost containment measures adopted by regulators and payers across key markets
To offset the revenue loss triggered by major patent expirations, companies have moved towards innovative therapies—often biologics—for niche indications with… Read the rest
The retail sector is a significant contributor to a country’s economy. In 2010, retail consumption accounted for two-thirds of the U.S. gross domestic product at $4.35 trillion. In the UK, retail sales were over £293 billion, according to the British Retail Consortium.
The retail industry has seen upheaval with the global economic crisis and intensely competitive environment, where margins are slimming down and customer loyalty is constantly fluctuating. It is critical for retailers to obtain insights to decide how much and what merchandize to stock, how to operate, and which customers they should fight to retain so that they can… Read the rest

Analytics beyond patterns
All successful Financial Service providers are exploring analytics to manage business. An important aspect of analytics is to use historic patterns to determine future trends. Thus the knowledge of fraud patterns can be used to strengthen fraud management.
Regulations changing risk analytics needs
Maintaining an organization or individual risk score card was once confined to larger organizations. Bureaus filled the gap by offering a unified approach to scoring based on behavioral attributes, which appealed to smaller firms. The evolution of business intelligence and analytical tools has helped smaller organizations adopt analytical insights and risk-grid-based pricing to… Read the rest
On the heels of well-grounded success in Clinical Research Outsourcing (CRO), the ever-evolving pharmaceutical industry is exploring new ways to leverage outsourcing to address challenges of increasing cost pressures and shorter drug-development cycle times. Pharma companies are turning to Functional Service Providers (FSPs). FSPs provide services function by function but have the added advantage of providing full service through IT+BPO+IS. India’s service providers are on the leading edge of FSP services and are positioned for helping pharmaceutical companies transition to a single strategic partnership model for clinical trials. I spoke with VK Raman, Head of Domain BPO Services at TCS,… Read the rest
Shared services centers and outsourcing are both hot with today’s businesses looking to cut costs and increase efficiencies as much as possible. What are the differences between the two models? This is Part II of a three-part roundtable discussion on important perspectives on these popular business models. Part II roundtable participants are Krist Davood, Group CIO of Schiavello; Joseph Soalheira, Advisory Board Member of the Shared Services & Outsourcing Network (SSON) global community; Asheesh Mehra, Head of Sales, Infosys BPO Asia Pacific; and Peter Barta, CEO of Everest Group Asia Pacific. All four are among many industry experts presenting at… Read the rest
Shared services centers and outsourcing are both hot with today’s businesses looking to cut costs and increase efficiencies as much as possible. What are the differences between the two models? This is Part III of a three-part roundtable discussion on important perspectives on these popular business models. Part III roundtable participants are Krist Davood, Group CIO of Schiavello; Joseph Soalheira, Advisory Board Member of the Shared Services & Outsourcing Network (SSON) global community; Asheesh Mehra, Head of Sales, Infosys BPO Asia Pacific; and Peter Barta, CEO of Everest Group Asia Pacific. All four are among many industry experts presenting at… Read the rest

It is a Formula One Grand Prix. Crew members are crunching data from the sensors attached to the car. In a single season, a team will burn 200,000 liters of fuel in testing to identify 50 slightly different blends of fuel additives. Subject to predictive and simulated models, the crew should be able to give the right blend of power boosting additives to touch the finish line!
Recent Comments
“Great interview with a top professional! Shared. Mel, alldayPA ”
“I like your orchestra analogy. I would like to start a discussion on knowledge transfer as a focus group for my ...”
“I am a university student studying alliance collaborations that involve sourcing of work internationally and would like to start a ...”
“Yes I totally agree with you price benchmark every year would be a great idea to keep up. ”
“nice share liked this article ”
“definitely cloud is there and its there to stay and also providing so many opportunities in it outsourcing ”
“Cloud computing is surely the new way of outsourcing. With IAAS, its takes the burden off the small and middle ...”
“I don't even understand how I stopped up right here, however I assumed this publish used to be great. I ...”